Nanalysis makes portable MRI machines for industrial applications, with revenue of $45 million per year, and is EBITDA positive. Products are patent protected and fully proprietary, and do not require liquid Helium as do conventional MRI machines.
The company sells its products direct and via dealers internationally. Customers are large pharma, biotech, food, and chemical companies, and universities world-wide.
The Company has proprietary manufacturing done domestically, and has a strong innovation pipeline, which includes vertical market specific software applications such as illicit drug detection and AI initiatives to make MRI machines smarter. Nanalysis’ revenue combines capital equipment sales with recuring services revenue.